MENU
ARVN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Arvinas (ARVN) Ownership - Who owns Arvinas?

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
395 Winchester Avenue
Phone
+1 203 535-1456
Employees
246
Web
https://www.arvinas.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
489.07M
P/E Ratio
N/A
Total Cash
614.9M
Projected Growth
N/A
Total Debt
8.4M
Revenue
89.4M
Risk (Beta)
2.57
Dividend Yield
N/A
Total Cash/Share
9.53
Total Debt/Equity
N/A
Revenue/Share
1.30 USD as % of share price
View a ticker or compare two or three
ARVN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of therapies to degrade disease-causing proteins

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
395 Winchester Avenue
Phone
+1 203 535-1456
Employees
246
Web
https://www.arvinas.com